These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 36122795)
1. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options. Xue W; Dong B; Wang Y; Xie Y; Li P; Gong Z; Niu Z Exp Mol Pathol; 2022 Oct; 128():104832. PubMed ID: 36122795 [TBL] [Abstract][Full Text] [Related]
2. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma. Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W Gene; 2022 Apr; 818():146177. PubMed ID: 35065254 [TBL] [Abstract][Full Text] [Related]
3. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer. Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725 [TBL] [Abstract][Full Text] [Related]
4. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling. Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054 [No Abstract] [Full Text] [Related]
5. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy. Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y Front Immunol; 2021; 12():665002. PubMed ID: 34367132 [TBL] [Abstract][Full Text] [Related]
6. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma. Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459 [TBL] [Abstract][Full Text] [Related]
7. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma. Zhou R; Peng N; Li W Front Immunol; 2022; 13():964919. PubMed ID: 36059494 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of vital genes correlated with CD8 + T cell infiltration as prognostic biomarkers in stomach adenocarcinoma. Pan D; Chen H; Xu J; Lin X; Li L BMC Gastroenterol; 2023 Nov; 23(1):399. PubMed ID: 37978443 [TBL] [Abstract][Full Text] [Related]
9. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets. Ren N; Liang B; Li Y Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704 [TBL] [Abstract][Full Text] [Related]
10. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs. Tu H; Zhang Q; Xue L; Bao J Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553481 [TBL] [Abstract][Full Text] [Related]
11. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
12. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma. Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388 [TBL] [Abstract][Full Text] [Related]
13. Construction of a Prognostic Evaluation Model for Stomach Adenocarcinoma on the Basis of Immune-Related lncRNAs. Xu C; Chen Z; Pan X; Liu M; Cheng G; Li J; Mei Y Appl Biochem Biotechnol; 2022 Dec; 194(12):6255-6269. PubMed ID: 35904674 [TBL] [Abstract][Full Text] [Related]
14. Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma. Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H PeerJ; 2024; 12():e16776. PubMed ID: 38274323 [TBL] [Abstract][Full Text] [Related]
15. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma. Chang J; Wu H; Wu J; Liu M; Zhang W; Hu Y; Zhang X; Xu J; Li L; Yu P; Zhu J J Transl Med; 2023 Mar; 21(1):191. PubMed ID: 36915111 [TBL] [Abstract][Full Text] [Related]
16. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
17. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer. Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918 [TBL] [Abstract][Full Text] [Related]
18. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma. Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435 [TBL] [Abstract][Full Text] [Related]
19. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma. Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma. Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]